Results 131 to 140 of about 6,357 (207)

Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study. [PDF]

BioDrugs, 2018
Stoppa G, D'Amore C, Conforti A, Traversa G, Venegoni M, Taglialatela M, Leone R, ESAVIEW Study Group.   +7 more
europepmc   +1 more source

Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study. [PDF]

Braz J Med Biol Res, 2018
Santos EJF, Santos EJF, Hortegal EV, Serra HO, Lages JS, Salgado-Filho N, Dos Santos AM.   +6 more
europepmc   +1 more source

Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease.

Clin J Am Soc Nephrol, 2018
Fishbane S, Singh B, Kumbhat S, Wisemandle WA, Martin NE.   +4 more
europepmc   +1 more source

Relationship between variations in time-dependent response to erythropoiesis-stimulating agents and mortality in hemodialysis patients: a single-center study [PDF]

, 2016
KATAOKA Hiroshi, KAWAGUCHI Hiroshi, KOMATSU Mizuki, NAGANUMA Toshiaki, NITTA Kosaku, OKAZAKI Masayuki, SHIOHIRA Shunji, TSUCHIYA Ken   +7 more
core   +2 more sources

Relative safety of peginesatide and epoetin alfa. [PDF]

Pharmacoepidemiol Drug Saf, 2014
Weinhandl ED, Gilbertson DT, Collins AJ, Foley RN.   +3 more
europepmc   +1 more source

Corrigendum: Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open-label, parallel-group, noninferiority phase III trial. [PDF]

Chronic Dis Transl Med
europepmc   +1 more source

Efficacy, safety, and immunogenicity of UB-851 versus ® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trial. [PDF]

J Chin Med Assoc
Wu CH, Shiao CC, Wang HY, Tian YC, Chiu YW, Huang WH, Tsai SH, Fang HC, Lee CC, Hsu BG, Chang HR, Lin CY, Chan CH, Wang WJ, Huang KC, Chen SC, Wang CL, Huang CY, Tarng DC.   +18 more
europepmc   +1 more source

Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia. [PDF]

J Clin Oncol, 2016
Gross I, Farmer S, Hofmann A, Ozawa S, Shander A, Aapro M.   +5 more
europepmc   +1 more source

Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.

Am J Nephrol, 2018
Thadhani R, Guilatco R, Hymes J, Maddux FW, Ahuja A.   +4 more
europepmc   +1 more source